Specify a stock or a cryptocurrency in the search bar to get a summary
Eliem Therapeutics Inc
ELYMEliem Therapeutics, Inc., a biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems. The company was incorporated in 2018 and is headquartered in Wilmington, Delaware. Address: PMB #117, 2801 Centerville Road, Wilmington, DE, United States, 19808-1609
Analytics
WallStreet Target Price
4.5 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ELYM
Dividend Analytics ELYM
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ELYM
Stock Valuation ELYM
Financials ELYM
Results | 2019 | Dynamics |